GBT Announces Pricing of Upsized Offering of $300.0 Million of Convertible Senior Notes
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2023 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the pricing of $300.0 million aggregate principal amount of its Convertible Senior Notes due 2028 (the “notes”) in a private offering…